The Journal of Immunology, Vol 145, Issue 10 3223-3230, Copyright © 1990 by American Association of Immunologists

ARTICLES

Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase

JM Trevillyan, YL Lu, D Atluru, CA Phillips and JM Bjorndahl
Veterans Affairs Medical Center, Texas Tech University Health Sciences Center, Amarillo 79106.

Engagement of the TCR (CD3-Ti) by Ag/MHC, CD3 mAb, or lectin mitogen stimulates the very early tyrosine phosphorylation of several cellular substrates including TCR-zeta. The T cell specific protein-tyrosine kinase (PTK), p56lck, has been implicated in the tyrosine phosphorylation of TCR-zeta. However, the significance of this event with regard to CD3-Ti signal transduction remains unclear. Herein, we have investigated the effect of the selective PTK inhibitor genistein (4',5,7-trihydroxyisoflavone) on cellular events associated with activation via CD3-Ti triggering. Genistein inhibited the T cell PTK, p56lck, in a dose-dependent fashion with an ID50 = 40 microM. Genistein also inhibited CD3 mAb or PHA-induced TCR-zeta chain phosphorylation in intact peripheral blood T cells. Genistein blocked the expression of IL- 2 and IL-2R (CD25) in T cells stimulated with PHA/PMA or CD3 mAb/PMA, but did not inhibit the de novo expression of the CD69 early activation Ag, which is induced primarily by a PKC-dependent pathway. IL-2 and CD25 expression induced by calcium ionophore A23187 and PMA was largely refractory to inhibition by genistein, suggesting an effect of the drug on calcium-dependent pathways stimulated via CD3-Ti triggering. In this last regard, genistein partially inhibited the CD3 mAb-induced rise in [Ca2+]i but did not inhibit PHA- or CD3 mAb-induced phosphatidylinositol hydrolysis. Consequently, protein-tyrosine phosphorylation does not appear to be a prerequisite for CD3-Ti- mediated activation of phosphatidylinositol-specific phospholipase C activity and PIP2 hydrolysis. An alternative role for PTK in CD3-Ti signal transduction is suggested.

This article has been cited by other articles:

				V. Selvaraj, D. Bunick, C. Finnigan-Bunick, R. W. Johnson, H. Wang, L. Liu, and P. S. Cooke Gene Expression Profiling of 17{beta}-Estradiol and Genistein Effects on Mouse Thymus Toxicol. Sci., September 1, 2005; 87(1): 97 - 112. [Abstract] [Full Text] [PDF]

				A. Hikosaka, M. Asamoto, N. Hokaiwado, K. Kato, K. Kuzutani, K. Kohri, and T. Shirai Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis, March 1, 2004; 25(3): 381 - 387. [Abstract] [Full Text] [PDF]

				W. Duan, I. C. Kuo, S. Selvarajan, K. Y. Chua, B. H. Bay, and W. S. F. Wong Antiinflammatory Effects of Genistein, a Tyrosine Kinase Inhibitor, on a Guinea Pig Model of Asthma Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 185 - 192. [Abstract] [Full Text] [PDF]

				T. P. O'Connor, D. A. Liesen, P. C. Mann, L. Rolando, and W. J. Banz A High Isoflavone Soy Protein Diet and Intravenous Genistein Delay Rejection of Rat Cardiac Allografts J. Nutr., August 1, 2002; 132(8): 2283 - 2287. [Abstract] [Full Text] [PDF]

				D. J. Elzi, A. J. Bjornsen, T. MacKenzie, T. H. Wyman, and C. C. Silliman Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils Am J Physiol Cell Physiol, July 1, 2001; 281(1): C350 - C360. [Abstract] [Full Text] [PDF]

				E. Middleton Jr., C. Kandaswami, and T. C. Theoharides The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751. [Abstract] [Full Text] [PDF]

				L. B. Clark, M. W. Appleby, M. E. Brunkow, J. E. Wilkinson, S. F. Ziegler, and F. Ramsdell Cellular and Molecular Characterization of the scurfy Mouse Mutant J. Immunol., March 1, 1999; 162(5): 2546 - 2554. [Abstract] [Full Text] [PDF]

				T. H. Kalb, X. Y. Yio, and L. Mayer Human Airway Epithelial Cells Stimulate T-Lymphocyte Lck and Fyn Tyrosine Kinase Am. J. Respir. Cell Mol. Biol., November 1, 1997; 17(5): 561 - 570. [Abstract] [Full Text]

				J. H. Hanke, J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, and P. A. Connelly Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor J. Biol. Chem., January 12, 1996; 271(2): 695 - 701. [Abstract] [Full Text] [PDF]

				X. Xu, J. W. Williams, E. G. Bremer, A. Finnegan, and A. S.-F. Chong Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide J. Biol. Chem., May 26, 1995; 270(21): 12398 - 12403. [Abstract] [Full Text] [PDF]

				F. Uckun, W. Evans, C. Forsyth, K. Waddick, L. Ahlgren, L. Chelstrom, A Burkhardt, J Bolen, and D. Myers Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases Science, February 10, 1995; 267(5199): 886 - 891. [Abstract] [PDF]